Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PHR
|
Chaim Indig
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 21,692 Reduced 1.72% |
$592,408
$27.31 p/Share
|
Jan 21
2025 |
|
EA
|
Andrew Wilson
Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.0% |
$713,750
$142.75 p/Share
|
Jan 21
2025 |
|
PHR
|
David Linetsky
SVP, Life Sciences |
SELL
Open market or private sale
|
Direct | 13,873 Reduced 5.85% |
$378,871
$27.31 p/Share
|
Jan 21
2025 |
|
UTHR
|
Michael Benkowitz
PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$3,657,000
$365.7 p/Share
|
Jan 21
2025 |
|
HOMB
|
John W Allison
Chairman & CEO |
BUY
Open market or private purchase
|
Direct | 10,000 Added 0.18% |
$307,600
$30.76 p/Share
|
Jan 21
2025 |
|
COIN
|
Frederick Ernest Ehrsam Iii
Director |
SELL
Open market or private sale
|
Indirect | 25,194 Reduced 0.0% |
$7,546,610
$299.54 p/Share
|
Jan 21
2025 |
|
ONTO
|
Michael P Plisinski
CEO |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 18.87% |
$7,671,650
$219.19 p/Share
|
Jan 21
2025 |
|
CNTA
|
Saurabh Saha
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 55,000 Reduced 11.35% |
$878,900
$15.98 p/Share
|
Jan 21
2025 |
|
DOCN
|
Bratin Saha
Chief Product & Tech Officer |
SELL
Open market or private sale
|
Direct | 4,289 Reduced 1.14% |
$157,835
$36.8 p/Share
|
Jan 21
2025 |
|
PLMR
|
Mac Armstrong
CEO and Chairman |
SELL
Open market or private sale
|
Indirect | 7,000 Reduced 0.0% |
$771,400
$110.2 p/Share
|
Jan 21
2025 |
|
PODD
|
Eric Benjamin
EVP, CPXPO |
SELL
Open market or private sale
|
Direct | 12,394 Reduced 52.13% |
$3,470,320
$280.0 p/Share
|
Jan 21
2025 |
|
ISSC
|
Christopher Harborne
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 98,600 Reduced 0.0% |
$1,066,852
$10.82 p/Share
|
Jan 21
2025 |
|
AVDL
|
Linda Palczuk
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 6.86% |
$39,650
$7.93 p/Share
|
Jan 21
2025 |
|
UDMY
|
Naspers LTD |
SELL
Open market or private sale
|
Indirect | 3,200,000 Reduced 0.0% |
$25,088,000
$7.84 p/Share
|
Jan 21
2025 |
|
INCY
|
Steven H Stein
EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 12,352 Reduced 15.57% |
$897,866
$72.69 p/Share
|
Jan 21
2025 |
|
BAND
|
Richard Brandon Asbill
General Counsel |
SELL
Open market or private sale
|
Direct | 499 Reduced 1.11% |
$7,988
$16.01 p/Share
|
Jan 21
2025 |
|
CLXT
|
Gerhard Prante
Director |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 2.97% |
$2,875
$2.5 p/Share
|
Jan 21
2025 |
|
PRTHW
|
Ranjana Ram
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 6,615 Reduced 0.95% |
$49,215
$7.44 p/Share
|
Jan 21
2025 |
|
PRTHW
|
John Vito Priore
Director |
SELL
Open market or private sale
|
Direct | 1,242,856 Reduced 23.39% |
$9,246,848
$7.44 p/Share
|
Jan 21
2025 |
|
PRTHW
|
Thomas Charles Priore
President, CEO and Chairman |
SELL
Open market or private sale
|
Direct | 105,833 Reduced 0.31% |
$787,397
$7.44 p/Share
|
Jan 21
2025 |
|
PSMT
|
Michael Mc Cleary
EVP & CFO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 6.44% |
$358,680
$89.67 p/Share
|
Jan 21
2025 |
|
IPI
|
Robert P Jornayvaz Iii
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 24,567 Reduced 19.01% |
$661,589
$26.93 p/Share
|
Jan 21
2025 |
|
NGS
|
Stephen Charles Taylor
Director |
SELL
Open market or private sale
|
Direct | 19,400 Reduced 4.24% |
$558,526
$28.79 p/Share
|
Jan 21
2025 |
|
MKZR
|
Robert E Dixon
CEO/President |
BUY
Open market or private purchase
|
Direct | 15,000 Added 27.27% |
$38,400
$2.56 p/Share
|
Jan 21
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 870 Added 0.0% |
$2,436
$2.8 p/Share
|
Jan 21
2025 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Direct | 328 Added 0.62% |
$918
$2.8 p/Share
|
Jan 21
2025 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$1,395
$1395.68 p/Share
|
Jan 21
2025 |
|
BDX
|
Shana Carol Neal
EVP and Chief People Officer |
SELL
Open market or private sale
|
Direct | 787 Reduced 4.86% |
$188,880
$240.0 p/Share
|
Jan 21
2025 |
|
BDX
|
David Shan
EVP and Chief ISC Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 8.01% |
$120,000
$240.0 p/Share
|
Jan 21
2025 |
|
ANIX
|
Lewis H Titterton Jr
Director |
BUY
Open market or private purchase
|
Direct | 6,000 Added 0.64% |
$15,540
$2.59 p/Share
|
Jan 21
2025 |
|
ACN
|
Melissa A Burgum
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,487 Reduced 13.85% |
$525,401
$353.33 p/Share
|
Jan 21
2025 |
|
PCYG
|
Randall K Fields
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 7,500 Reduced 0.0% |
$162,675
$21.69 p/Share
|
Jan 21
2025 |
|
MDBH
|
Anthony Digiandomenico
Co-Founder |
BUY
Open market or private purchase
|
Direct | 1,000 Added 1.15% |
$6,210
$6.21 p/Share
|
Jan 21
2025 |
|
MGTX
|
Richard Giroux
CFO & COO |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 2.75% |
$150,960
$6.29 p/Share
|
Jan 21
2025 |
|
AURA
|
Pinos Elisabet De Los |
SELL
Open market or private sale
|
Direct | 15,955 Reduced 4.98% |
$122,374
$7.67 p/Share
|
Jan 21
2025 |
|
AURA
|
Amy Elazzouzi
Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct | 1,001 Reduced 2.54% |
$7,677
$7.67 p/Share
|
Jan 21
2025 |
|
HRMY
|
Jeffrey Dierks
CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,123 Reduced 100.0% |
$44,920
$40.0 p/Share
|
Jan 21
2025 |
|
SLB
|
Khaled Al Mogharbel
EVP, Geographies |
SELL
Open market or private sale
|
Direct | 123,097 Reduced 40.0% |
$5,423,653
$44.06 p/Share
|
Jan 21
2025 |
|
SLB
|
Vijay Kasibhatla
Director, M&A |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 33.51% |
$1,098,500
$43.94 p/Share
|
Jan 21
2025 |
|
SLB
|
Dianne B. Ralston
Chief Legal Officer & Sec |
SELL
Open market or private sale
|
Direct | 43,161 Reduced 15.52% |
$1,897,357
$43.96 p/Share
|
Jan 21
2025 |
|
SLB
|
Howard Guild
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 13,568 Reduced 35.43% |
$595,228
$43.87 p/Share
|
Jan 21
2025 |
|
SLB
|
Ugo Prechner
VP Controller |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 38.38% |
$309,400
$44.2 p/Share
|
Jan 21
2025 |
|
SLB
|
Stephane Biguet
EVP & CFO |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 17.89% |
$1,974,150
$43.87 p/Share
|
Jan 21
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 21,000 Added 0.0% |
$147,630
$7.03 p/Share
|
Jan 21
2025 |
|
GWRE
|
Michael George Rosenbaum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,400 Reduced 0.5% |
$251,874
$179.91 p/Share
|
Jan 21
2025 |
|
TYRA
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect | 3,993 Reduced 0.0% |
$65,325
$16.36 p/Share
|
Jan 21
2025 |
|
AGYS
|
Kaufman 2012 Descendants Trust, David N. Smith, Trustee |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 2.93% |
$941,175
$125.49 p/Share
|
Jan 21
2025 |
|
EXPI
|
Glenn Darrel Sanford
CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 0.06% |
$286,000
$11.44 p/Share
|
Jan 21
2025 |
|
K
|
Kellogg W K Foundation Trust |
SELL
Open market or private sale
|
Direct | 114,583 Reduced 0.24% |
$9,360,285
$81.69 p/Share
|
Jan 21
2025 |
|
RYAN
|
Nicholas Dominic Cortezi
Director |
SELL
Open market or private sale
|
Indirect | 35,000 Reduced 0.0% |
$2,331,350
$66.61 p/Share
|
Jan 21
2025 |